Merck & Co., Inc.
MRK
$115.88
$2.882.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.70% | -5.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.70% | -5.07% | |||
| Cost of Revenue | -9.78% | 14.69% | |||
| Gross Profit | 2.53% | -10.54% | |||
| SG&A Expenses | -6.11% | 10.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.31% | 7.80% | |||
| Operating Income | 16.97% | -23.75% | |||
| Income Before Tax | -203.33% | -49.30% | |||
| Income Tax Expenses | 54.80% | -52.19% | |||
| Earnings from Continuing Operations | -243.25% | -48.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 200.00% | 150.00% | |||
| Net Income | -243.10% | -48.78% | |||
| EBIT | 16.97% | -23.75% | |||
| EBITDA | 13.22% | -16.62% | |||
| EPS Basic | -244.03% | -48.64% | |||
| Normalized Basic EPS | 18.34% | -26.16% | |||
| EPS Diluted | -244.43% | -48.64% | |||
| Normalized Diluted EPS | 18.34% | -26.07% | |||
| Average Basic Shares Outstanding | -0.64% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.64% | -0.40% | |||
| Dividend Per Share | 4.94% | 0.00% | |||
| Payout Ratio | -1.73% | 0.94% | |||